5-Methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone(CAS: 636-26-0)

5-Methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone (CAS: 636-26-0) must comply with the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for hazardous substances. In the European Union, it falls under the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulations. Additionally, the US FDA and EPA have specific guidelines for handling and disposal that must be followed.

Alternative reagents like N-methyl-2-imidazolidinone or 5-aminopyrimidine can be used as substitutes in the synthesis of 5-Methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone (CAS: 636-26-0). These alternatives offer similar functional groups and can be adapted based on specific reaction conditions and desired product purity.

The market for 5-Methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone (CAS: 636-26-0) is trending towards increasing research in drug development and pharmaceutical applications, particularly in antiviral and anticancer therapies. Recent studies are exploring its potential as a bioactive compound, leading to advancements in synthetic chemistry and pharmaceutical formulation techniques.

Waste containing 5-Methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone (CAS: 636-26-0) should be collected in sealed containers and stored separately to prevent contamination. It should then be incinerated or disposed of through professional waste disposal services to ensure compliance with environmental regulations. Adequate protective measures and personal protective equipment (PPE) should be used during handling to protect against potential hazards.